PROTRIEVE
DEAD

Serial Number

86543084

Owner

ALLERGAN FINANCE, LLC

Attorney

Matthew O. Brady

Filing Date

Feb 23, 2015

Add to watchlist:

No watchlists yet
View on USPTO

PROTRIEVE Trademark

Serial Number: 86543084

PROTRIEVE is a trademark filed by ALLERGAN FINANCE, LLC on February 23, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ALLERGAN FINANCE, LLC (37 trademarks)

400 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Entity Type: 16

ACTAVIS, INC. (216 trademarks)

400 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Entity Type: 03

Trademark Details

Filing Date

February 23, 2015

Registration Date

Not Registered

Published for Opposition

August 18, 2015

Goods & Services

Oral, transdermal, injectable and intravaginal contraceptive preparations, intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, Central Nervous System disease and disorders, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent for medical purposes; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Nov 19, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 19, 2018 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 17, 2018 EXRA
SOU EXTENSION 5 GRANTED
Apr 16, 2018 EX5G
SOU EXTENSION 5 FILED
Apr 12, 2018 EXT5
SOU TEAS EXTENSION RECEIVED
Apr 12, 2018 EEXT
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 3, 2018 ASCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 5, 2017 EXRA
SOU EXTENSION 4 GRANTED
Oct 3, 2017 EX4G
SOU EXTENSION 4 FILED
Oct 3, 2017 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 3, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 30, 2017 EXRA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 29, 2017 ASGN
SOU EXTENSION 3 GRANTED
Mar 29, 2017 EX3G
SOU EXTENSION 3 FILED
Mar 22, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 22, 2017 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 30, 2017 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 25, 2016 EXRA
SOU EXTENSION 2 GRANTED
Oct 24, 2016 EX2G
SOU EXTENSION 2 FILED
Oct 10, 2016 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 10, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2016 EXRA
SOU EXTENSION 1 GRANTED
May 16, 2016 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 11, 2016 AITU
SOU EXTENSION 1 FILED
Apr 8, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 8, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 13, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 18, 2015 NPUB
PUBLISHED FOR OPPOSITION
Aug 18, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 29, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 16, 2015 PREV
ASSIGNED TO LIE
Jul 8, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 23, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 17, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 1, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jun 1, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jun 1, 2015 CNRT
ASSIGNED TO EXAMINER
May 29, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 9, 2015 NWOS
NEW APPLICATION ENTERED
Feb 26, 2015 NWAP